[Clinical observations on the action of NC 123, a new medium tranquilizer].
D000328:Adult; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D003919:Diabetes Insipidus / Q000188:drug therapy; D004402:Dysautonomia, Familial / Q000188:drug therapy; D005260:Female; D006111:Graves Disease / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D051379:Mice; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D014149:Tranquilizing Agents
Klinische Beobachtungen über die Wirkung von NC 123, einem neuen Medium-Tranquillizer.